United States Antidiabetic Thiazolidinediones Market Report 2017

January 2017 | 95 pages | ID: U97444A3BDCEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antidiabetic Thiazolidinediones

Revenue, means the sales value of Antidiabetic Thiazolidinediones

This report studies sales (consumption) of Antidiabetic Thiazolidinediones in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sanofi
• Takeda Pharmaceuticals
• Eli Lilly
• Merck & Co.
• Novo Nordisk
• Bristol-Myers Squibb
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Boehringer Ingelheim

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Rosiglitazone
• Pioglitazone

Split by applications, this report focuses on sales, market share and growth rate of Antidiabetic Thiazolidinediones in each application, can be divided into

• Hospital
• Clinic

Contents

United States Antidiabetic Thiazolidinediones Market Report 2017

1 ANTIDIABETIC THIAZOLIDINEDIONES OVERVIEW

1.1 Product Overview and Scope of Antidiabetic Thiazolidinediones
1.2 Classification of Antidiabetic Thiazolidinediones
  1.2.1 Rosiglitazone
  1.2.2 Pioglitazone
1.3 Application of Antidiabetic Thiazolidinediones
  1.3.1 Hospital
  1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Antidiabetic Thiazolidinediones (2011-2021)
  1.4.1 United States Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2021)
  1.4.2 United States Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTIDIABETIC THIAZOLIDINEDIONES COMPETITION BY MANUFACTURERS

2.1 United States Antidiabetic Thiazolidinediones Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antidiabetic Thiazolidinediones Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antidiabetic Thiazolidinediones Average Price by Manufactures (2015 and 2016)
2.4 Antidiabetic Thiazolidinediones Market Competitive Situation and Trends
  2.4.1 Antidiabetic Thiazolidinediones Market Concentration Rate
  2.4.2 Antidiabetic Thiazolidinediones Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTIDIABETIC THIAZOLIDINEDIONES SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Antidiabetic Thiazolidinediones Sales and Market Share by States (2011-2016)
3.2 United States Antidiabetic Thiazolidinediones Revenue and Market Share by States (2011-2016)
3.3 United States Antidiabetic Thiazolidinediones Price by States (2011-2016)

4 UNITED STATES ANTIDIABETIC THIAZOLIDINEDIONES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Antidiabetic Thiazolidinediones Sales and Market Share by Type (2011-2016)
4.2 United States Antidiabetic Thiazolidinediones Revenue and Market Share by Type (2011-2016)
4.3 United States Antidiabetic Thiazolidinediones Price by Type (2011-2016)
4.4 United States Antidiabetic Thiazolidinediones Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ANTIDIABETIC THIAZOLIDINEDIONES SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Antidiabetic Thiazolidinediones Sales and Market Share by Application (2011-2016)
5.2 United States Antidiabetic Thiazolidinediones Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIDIABETIC THIAZOLIDINEDIONES MANUFACTURERS PROFILES/ANALYSIS

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.1.2.1 Rosiglitazone
    6.1.2.2 Pioglitazone
  6.1.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Takeda Pharmaceuticals
  6.2.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.2.2.1 Rosiglitazone
    6.2.2.2 Pioglitazone
  6.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.3.2.1 Rosiglitazone
    6.3.2.2 Pioglitazone
  6.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co.
  6.4.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.4.2.1 Rosiglitazone
    6.4.2.2 Pioglitazone
  6.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Novo Nordisk
  6.5.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.5.2.1 Rosiglitazone
    6.5.2.2 Pioglitazone
  6.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb
  6.6.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.6.2.1 Rosiglitazone
    6.6.2.2 Pioglitazone
  6.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.7.2.1 Rosiglitazone
    6.7.2.2 Pioglitazone
  6.7.3 Pfizer Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 AstraZeneca
  6.8.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.8.2.1 Rosiglitazone
    6.8.2.2 Pioglitazone
  6.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 GlaxoSmithKline
  6.9.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.9.2.1 Rosiglitazone
    6.9.2.2 Pioglitazone
  6.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Boehringer Ingelheim
  6.10.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification
    6.10.2.1 Rosiglitazone
    6.10.2.2 Pioglitazone
  6.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview

7 ANTIDIABETIC THIAZOLIDINEDIONES MANUFACTURING COST ANALYSIS

7.1 Antidiabetic Thiazolidinediones Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antidiabetic Thiazolidinediones

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antidiabetic Thiazolidinediones Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antidiabetic Thiazolidinediones Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIDIABETIC THIAZOLIDINEDIONES MARKET FORECAST (2016-2021)

11.1 United States Antidiabetic Thiazolidinediones Sales, Revenue Forecast (2016-2021)
11.2 United States Antidiabetic Thiazolidinediones Sales Forecast by Type (2016-2021)
11.3 United States Antidiabetic Thiazolidinediones Sales Forecast by Application (2016-2021)
11.4 Antidiabetic Thiazolidinediones Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic Thiazolidinediones
Table Classification of Antidiabetic Thiazolidinediones
Figure United States Sales Market Share of Antidiabetic Thiazolidinediones by Type in 2015
Figure Rosiglitazone Picture
Figure Pioglitazone Picture
Table Application of Antidiabetic Thiazolidinediones
Figure United States Sales Market Share of Antidiabetic Thiazolidinediones by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2021)
Figure United States Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)
Table United States Antidiabetic Thiazolidinediones Sales of Key Manufacturers (2015 and 2016)
Table United States Antidiabetic Thiazolidinediones Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antidiabetic Thiazolidinediones Sales Share by Manufacturers
Figure 2016 Antidiabetic Thiazolidinediones Sales Share by Manufacturers
Table United States Antidiabetic Thiazolidinediones Revenue by Manufacturers (2015 and 2016)
Table United States Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antidiabetic Thiazolidinediones Revenue Share by Manufacturers
Table 2016 United States Antidiabetic Thiazolidinediones Revenue Share by Manufacturers
Table United States Market Antidiabetic Thiazolidinediones Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antidiabetic Thiazolidinediones Average Price of Key Manufacturers in 2015
Figure Antidiabetic Thiazolidinediones Market Share of Top 3 Manufacturers
Figure Antidiabetic Thiazolidinediones Market Share of Top 5 Manufacturers
Table United States Antidiabetic Thiazolidinediones Sales by States (2011-2016)
Table United States Antidiabetic Thiazolidinediones Sales Share by States (2011-2016)
Figure United States Antidiabetic Thiazolidinediones Sales Market Share by States in 2015
Table United States Antidiabetic Thiazolidinediones Revenue and Market Share by States (2011-2016)
Table United States Antidiabetic Thiazolidinediones Revenue Share by States (2011-2016)
Figure Revenue Market Share of Antidiabetic Thiazolidinediones by States (2011-2016)
Table United States Antidiabetic Thiazolidinediones Price by States (2011-2016)
Table United States Antidiabetic Thiazolidinediones Sales by Type (2011-2016)
Table United States Antidiabetic Thiazolidinediones Sales Share by Type (2011-2016)
Figure United States Antidiabetic Thiazolidinediones Sales Market Share by Type in 2015
Table United States Antidiabetic Thiazolidinediones Revenue and Market Share by Type (2011-2016)
Table United States Antidiabetic Thiazolidinediones Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antidiabetic Thiazolidinediones by Type (2011-2016)
Table United States Antidiabetic Thiazolidinediones Price by Type (2011-2016)
Figure United States Antidiabetic Thiazolidinediones Sales Growth Rate by Type (2011-2016)
Table United States Antidiabetic Thiazolidinediones Sales by Application (2011-2016)
Table United States Antidiabetic Thiazolidinediones Sales Market Share by Application (2011-2016)
Figure United States Antidiabetic Thiazolidinediones Sales Market Share by Application in 2015
Table United States Antidiabetic Thiazolidinediones Sales Growth Rate by Application (2011-2016)
Figure United States Antidiabetic Thiazolidinediones Sales Growth Rate by Application (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic Thiazolidinediones
Figure Manufacturing Process Analysis of Antidiabetic Thiazolidinediones
Figure Antidiabetic Thiazolidinediones Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic Thiazolidinediones Major Manufacturers in 2015
Table Major Buyers of Antidiabetic Thiazolidinediones
Table Distributors/Traders List
Figure United States Antidiabetic Thiazolidinediones Production and Growth Rate Forecast (2016-2021)
Figure United States Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)
Table United States Antidiabetic Thiazolidinediones Production Forecast by Type (2016-2021)
Table United States Antidiabetic Thiazolidinediones Consumption Forecast by Application (2016-2021)
Table United States Antidiabetic Thiazolidinediones Sales Forecast by States (2016-2021)
Table United States Antidiabetic Thiazolidinediones Sales Share Forecast by States (2016-2021)